
President and Chief Executive Officer, GM Global
Member of the Healthcare Council
Glen McDaniel, MS, MBA, is the President and Chief Executive Officer of GM Global. He specializes in clinical chemistry and organizational management. Mr. McDaniel has been a healthcare consultant consulting on Long Term Acute Care, hospital operations, clinical lab science, ethics, decision making, and organizational effectiveness to major companies. He has served as the Chief Operating Officer of Kindred Hospital. Mr. McDaniel is a published writer and speaker on topics including clinical laboratory sciences, hospital operations, and long term acute care. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Roche adds to anti-MRSA arsenal in Europe
April 8, 2009
Roche introduces new LightCycler MRSA advanced test in EU | www.roche.com
European healthcare organizations have always been more aggressive in identifying MRSA infections. Europe popularized the "search and destroy" protocol of MRSA containment. This new method by Roche is a valuable addition in this arsenal. I expect the LightCycler MRSA Test by Roche to be popular and very lucrative for Roche.
Boomers numbers and demands point to increased demand for medical real estate
July 1, 2008
Aging Baby Boomers Will Drive Demand for Healthcare Properties Over Next Decade, Grubb & Ellis Report Reveals | www.bio-medicine.org
Baby boomers are rapidly aging. According to Census Bureau by 2010 there will be 77 million people aged 55 and older; a number which will grow to a whopping 98 million by 2020. This aging population, living longer with chronic illnesses and more demanding of cafeteria-type service will drive the demand for medical services and more medical real estate into the forseeable future.
Screening babies for cholesterol has no scientific basis
October 5, 2007
Screening: Testing Early for Cholesterol | www.nytimes.com
Hypercholesterolemia has an established link with a risk of cardiac events and there has been a push to screen high risk population for early intervention in an effort to reduce the incidence of heart attacks and strokes, for example. However to suggest any benefit from screening babies is to misunderstand the science and is immediately suspect in my view. Such a measure if adopted would increase healthcare costs and cause undue worry for parents, with no corresponding ability to mitigate the risk they are now told exists.
Nursing Homes Owned by Private Equity Firms Worse in Quality?
October 5, 2007
Senators seek private equity nursing home probe | www.reuters.com
Recently there has been a rash of takeover of publicly owned nursing homes by private equity firms flush with cash. There is a concomitant suspicion now that quality is being compromised systematically in these institutions in order to maximize profits. It's important to ascertain if this is so. If it is, there could be a whole new rash of regulations geared towards acquisitions and/or the nursing home industry.
SCHIP legislation vetoed by President Bush
October 4, 2007
Bush vetoes bill on children's health care | www.reuters.com
Many lower income families depend on the SCHIP program administered by individual states to pay for healthcare. Republicans see this as just another entitlement program while Democrats see it as an essential way of making sure children have access to the basics in healthcare. This veto might be based more on political than financial (and certainly medical) grounds.
November 20, 2007 | New York
GLGi: Long Term Acute Care Hospitals